ClinicalTrials.govpublic full text
Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
huntington's disease, dimebon, dose-escalation, phase 1-2a, randomized, controlled, double-blind, unified huntington's disease rating scale, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838880
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.